---
title: "Dolphin Medical Services Ltd (526504) — Share Price, Financials & Analysis"
symbol: "526504"
company: "Dolphin Medical Services Ltd"
canonical: "https://tapetide.com/stocks/526504"
isin: "INE796B01013"
bse_code: "526504"
sector: "Healthcare"
industry: "Healthcare Services"
market_cap_cr: 9.5
generated_at: "2026-09-13T18:58:51.365Z"
---

# Dolphin Medical Services Ltd (526504)

Canonical page: https://tapetide.com/stocks/526504

## Company

- **BSE Code:** 526504
- **ISIN:** INE796B01013
- **Sector:** Healthcare
- **Industry:** Healthcare Services
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2006-03-01
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** dolphinmedicalservices.com

## About

Incorporated in 1984, Dolphin Medical Services Ltd is in the business of diagnostics and 
other allied services.[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-07T04:34:01.612128Z.

- **Market Cap:** ₹9.5 Cr
- **Classification:** Microcap
- **P/E (reported):** 221.3
- **EPS (TTM):** ₹0.04
- **Book Value:** ₹6.68
- **Price to Book:** 0.99
- **Dividend Yield:** 0%
- **ROE:** -0.36%
- **ROCE:** -0.06%
- **Debt to Equity:** 0.09
- **Revenue (yearly):** ₹0.7 Cr
- **Net Income:** ₹0 Cr
- **EBITDA:** ₹0.3 Cr
- **52-Week High:** ₹9.57
- **52-Week Low:** ₹1.98

## Key Insights

### Strengths

- Company is almost debt free.
- Stock is trading at 0.95 times its book value

### Weaknesses

- The company has delivered a poor sales growth of 9.80% over past five years.
- Promoter holding is low: 26.4%
- Company has a low return on equity of -0.23% over last 3 years.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | -100% | -100% | -100% |
| ebitda margin growth | 0% | -565.53% | — | — |
| net income growth | 0% | -100% | 36% | 17% |
| revenue growth | 0% | 75% | 7% | 10% |
| roce | 100% | -97.66% | — | — |
| roe | 100% | -91.93% | — | — |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 0.18 | 0.2 | 0.14 | 0.14 | 0.25 | 0.24 | 0.14 | 0.17 | 0.18 | 0.21 | 0.19 | 0.21 |
| Expenses | 0.17 | 0.2 | 0.27 | 0.13 | 0.23 | 0.23 | 0.19 | 0.14 | 0.16 | 0.18 | 0.17 | 0.18 |
| Operating Profit | 0.01 | 0 | -0.13 | 0.01 | 0.02 | 0.01 | -0.05 | 0.03 | 0.02 | 0.03 | 0.02 | 0.03 |
| OPM % | 5.56 | 0 | -92.86 | 7.14 | 8 | 4.17 | -35.71 | 17.65 | 11.11 | 14.29 | 10.53 | 14.29 |
| Other Income | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.03 | 0.01 | 0.03 | 0.03 | 0.02 | 0.02 |
| Profit before tax | 0.01 | 0 | -0.13 | 0.01 | 0.02 | 0.01 | -0.07 | 0.03 | 0 | 0.01 | 0.01 | 0.02 |
| Tax % | 0 | — | 7.69 | 0 | 0 | 0 | 0 | 0 | — | 0 | 0 | 0 |
| Net Profit | 0.01 | 0 | -0.13 | 0.01 | 0.02 | 0.01 | -0.07 | 0.03 | 0.01 | 0.02 | 0.01 | 0.02 |
| EPS in Rs | 0.01 | 0 | -0.09 | 0.01 | 0.01 | 0.01 | -0.05 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 0.15 | 0.06 | 0.18 | 0.47 | 0.52 | 0.61 | 0.68 | 0.78 | 0.75 | 0.79 |
| Expenses | 0.23 | 0.2 | 0.52 | 6.24 | 0.66 | 0.69 | 0.76 | 0.78 | 0.63 | 0.69 |
| Operating Profit | -0.08 | -0.14 | -0.34 | -5.77 | -0.14 | -0.08 | -0.08 | 0 | 0.12 | 0.1 |
| OPM % | -53.33 | -233.33 | -188.89 | -1227.66 | -26.92 | -13.11 | -11.76 | 0 | 16 | 12.66 |
| Other Income | 0.09 | -0.63 | 0.05 | 5.55 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
| Interest | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0 |
| Depreciation | 0.33 | 0.24 | 0.06 | 0.06 | 0.06 | 0.06 | 0.05 | 0.06 | 0.09 | 0.1 |
| Profit before tax | -0.33 | -1.02 | -0.36 | -0.29 | -0.17 | -0.11 | -0.1 | -0.03 | 0.06 | 0.04 |
| Tax % | -12.12 | -1.96 | 5.56 | 6.9 | 5.88 | 9.09 | 10 | 0 | 0 | — |
| Net Profit | -0.3 | -1.01 | -0.39 | -0.31 | -0.19 | -0.12 | -0.1 | -0.03 | 0.06 | 0.06 |
| EPS in Rs | -0.2 | -0.67 | -0.26 | -0.21 | -0.13 | -0.08 | -0.07 | -0.02 | 0.04 | 0.04 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 15.1 | 15.1 | 15.1 | 15.1 | 15.1 | 15.1 | 15.1 | 15.1 | 15.1 | 15.1 |
| Reserves | -2.61 | -2.91 | -3.91 | -4.3 | -4.61 | -4.8 | -4.92 | -5.03 | -5.06 | -5.02 |
| Borrowings | 8.21 | 8.21 | 6.22 | 6.37 | 0.61 | 0.68 | 0.76 | 0.8 | 0.87 | 0.87 |
| Other Liabilities | 0.65 | 0.61 | 0.58 | 0.71 | 1.23 | 1.26 | 1.23 | 1.27 | 1.17 | 1.48 |
| Total Liabilities | 21.35 | 21.01 | 17.99 | 17.88 | 12.33 | 12.24 | 12.17 | 12.14 | 12.08 | 12.43 |
| Fixed Assets | 10.03 | 9.7 | 6.79 | 6.74 | 3 | 2.94 | 2.87 | 2.83 | 2.76 | 6.91 |
| CWIP | 5.93 | 5.93 | 5.93 | 5.93 | 4.09 | 4.09 | 4.09 | 4.09 | 4.09 | 0.31 |
| Investments | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 |
| Other Assets | 4.98 | 4.97 | 4.86 | 4.8 | 4.83 | 4.8 | 4.8 | 4.81 | 4.82 | 4.8 |
| Total Assets | 21.35 | 21.01 | 17.99 | 17.88 | 12.33 | 12.24 | 12.17 | 12.14 | 12.08 | 12.43 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | -0.07 | 0 | 0.02 | -0.13 | 0.27 | -0.1 | -0.07 | -0.05 | -0.06 | 0.14 |
| Cash from Investing Activity | 0.03 | 0 | 1.97 | -0.01 | 0 | 0 | 0 | 0 | 0 | -0.45 |
| Cash from Financing Activity | 0.05 | 0 | -1.99 | 0.15 | -0.25 | 0.07 | 0.07 | 0.05 | 0.06 | 0.31 |
| Net Cash Flow | 0 | 0 | 0 | 0.01 | 0.03 | -0.02 | 0 | 0 | 0 | 0 |
| Free Cash Flow | -0.07 | 0 | 1.99 | -0.14 | 0.27 | -0.1 | -0.07 | -0.05 | -0.06 | -0.31 |
| CFO/OP | -200 | 0 | -14 | 38 | -5 | 71 | 88 | 62 | — | 117 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory Days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33.18 | 30.42 | 36.5 |
| Days Payable | — | — | — | — | — | — | — | 0 | 0 | 0 |
| Cash Conversion Cycle | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33.18 | 30.42 | 36.5 |
| Working Capital Days | 2106.57 | 4891 | 11619.17 | 3629.72 | 986.28 | 898.46 | 771.89 | 687.06 | 645.77 | 515.87 |
| ROCE % | -0.96 | -1.56 | -1.69 | -2.02 | -1.98 | -1.45 | -0.91 | -0.83 | -0.18 | 0.64 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 26.44% | 26.44% | 26.44% | 26.44% | 26.44% | 26.44% | 26.44% | 26.44% | 26.44% | 26.44% | 26.44% | 26.44% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 69.77% | 69.81% | 69.81% | 69.85% | 69.81% | 69.81% | 69.81% | 69.81% | 69.81% | 69.81% | 69.81% | 69.37% |
| Others | 3.79% | 3.74% | 3.74% | 3.71% | 3.74% | 3.74% | 3.74% | 3.74% | 3.74% | 3.74% | 3.74% | 4.19% |
| No. of Shareholders | 9136 | 9360 | 9349 | 9358 | 9349 | 9349 | 9349 | 9349 | 9349 | 9349 | 9349 | 10111 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 10 / 3 / 6

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 7.41 | Sell |
| EMA (10) | 7.13 | Sell |
| SMA (20) | 7.41 | Sell |
| EMA (20) | 6.98 | Sell |
| SMA (50) | 5.15 | Buy |
| EMA (50) | 5.68 | Buy |
| SMA (100) | 3.79 | Buy |
| EMA (100) | 4.45 | Buy |
| SMA (200) | 2.84 | Buy |
| EMA (200) | 3.58 | Buy |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 47.3 | Neutral |
| MACD (12,26,9) | 0.44 | Sell |
| Stochastic (14,3,3) | 1.82 | Buy |
| ADX (14) | 23.62 | Neutral |
| Williams %R (14) | -100 | Buy |
| ATR (14) | 0.7 | High Volatility |
| ROC (12) | -23.79 | Sell |
| Stoch RSI (14) | 0 | Buy |
| UO (7,14,28) | 20.97 | Buy |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 9h - Board meeting on 16 May 2026 to approve audited Q4 and FY2026 financial results. | [Board Meeting Intimation for Audited Financial Results For Quarter And Year Ended March 31, 2026 9h - Board meeting on 16 May 2026 to approve audited Q4 and FY2026 financial results.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/19485c0a-ab3f-403b-8a13-7e86f8c80e5c.pdf) |
| 7h - Board met on 22 Apr 2026; appointed Saikumar and Srujana as independent directors for 5 years, noted three resignations. | [Board Meeting Outcome for Appointment Of Directors 7h - Board met on 22 Apr 2026; appointed Saikumar and Srujana as independent directors for 5 years, noted three resignations.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/d16234c0-23be-4bbd-b158-39404c310638.pdf) |
| 7h - Board meeting on 22 April 2026 to consider independent director appointments, resignations, and committee reconstitution. | [Board Meeting Intimation for Apoointment Of Directors 7h - Board meeting on 22 April 2026 to consider independent director appointments, resignations, and committee reconstitution.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/68dbc049-4b57-4c67-9101-b33c066f838a.pdf) |
| 6h - Board approved two independent director appointments and noted three director resignations on 22 April 2026. | [Announcement under Regulation 30 (LODR)-Change in Management 6h - Board approved two independent director appointments and noted three director resignations on 22 April 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/2e31ebad-2a94-48da-a029-b2e1eeb2b9c7.pdf) |
| 6 Feb - Unaudited results for quarter/nine months ended 31.12.2025: Q3 revenue Rs21.53L, Q3 profit Rs1.68L, 9M profit Rs5.41L | [Standalone Unaudited Financial Results For The Quarter Ended December 31, 2025 6 Feb - Unaudited results for quarter/nine months ended 31.12.2025: Q3 revenue Rs21.53L, Q3 profit Rs1.68L, 9M profit Rs5.41L](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b21ccf5a-7831-4a51-a58b-3a7e1e17aa28.pdf) |
| 6 Feb - Unaudited Q3/9M results to 31-Dec-2025: total revenue Rs21.53L, Q3 profit Rs1.68L, 9M profit Rs5.41L. | [Board Meeting Outcome for Standalone Unaudited Financial Results For The Quarter Ended December 31, 2025 6 Feb - Unaudited Q3/9M results to 31-Dec-2025: total revenue Rs21.53L, Q3 profit Rs1.68L, 9M profit Rs5.41L.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4f00ecc4-67af-4582-8ea7-efa918f8da81.pdf) |
| 31 Jan - Dolphin Medical: Board meeting deferred from 30 Jan to 06 Feb 2026 to consider quarter results. | [Board Meeting Outcome for Intimation Of Deferment Of Board Meeting 31 Jan - Dolphin Medical: Board meeting deferred from 30 Jan to 06 Feb 2026 to consider quarter results.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0fec7a49-bf5a-4464-8965-86fc73139cdf.pdf) |
| 30 Mar - Trading window closed from April 1, 2026 until 48 hours after audited results for quarter/year ended March 31, 2026. | [Closure of Trading Window 30 Mar - Trading window closed from April 1, 2026 until 48 hours after audited results for quarter/year ended March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/77bb5bdb-f695-4591-b6df-af350e541fee.pdf) |
| 30 Mar - CFO Lakshmi Sudha Madala resigned effective 12 Feb 2026; corrigendum filed 30 Mar 2026. | [Corrigendum To Board Meeting Outcome Held On 12Th February, 2026. 30 Mar - CFO Lakshmi Sudha Madala resigned effective 12 Feb 2026; corrigendum filed 30 Mar 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f15f499d-9405-4429-bd9e-5837ace9597d.pdf) |
| 27 January 2026 - Transcript of Jan 23, 2026 investor meet: FY25 revenue ~85 Cr; H1FY26 acquisitions contributed ~8-9 Cr; AI, cybersecurity focus. | [Analysts/Institutional Investor Meet/Con. Call Updates 27 January 2026 - Transcript of Jan 23, 2026 investor meet: FY25 revenue ~85 Cr; H1FY26 acquisitions contributed ~8-9 Cr; AI, cybersecurity focus.](https://nsearchives.nseindia.com/corporate/ENSER06_27012026140009_Enser_transcript_finalsigned.pdf) |

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-03 | [Intimation Of Extension Of AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=abb99c62-757f-4998-ba83-6a0abcd188e3.pdf) |
| 2026-08-28 | [Post-Offer Advertisement](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=A4E2F570-BC80-430C-A42F-6C64FE87D99E-144003.pdf) |
| 2026-08-14 | [Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=40e7dbcf-c18d-4789-9fbd-b0b113e7a0e2.pdf) |
| 2026-08-09 | [Board Meeting Intimation for BM Intimation For BM Is Scheduled To Be Held On Thursday August 14 2026 Inter Alia To Consider & Approve The Unaudited Standalone Financial Results Of The Company For The 1St Quarter Ended June 30 2026 Of The Financial Year 20](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=02589072-5ca3-4935-b1be-ccd7bb695c18.pdf) |
| 2026-07-30 | [Updates on Open Offer](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=CEF997D2-80DF-47C3-829A-CD75A8EAD999-175753.pdf) |
| 2026-07-29 | [Recommendations of the Committee of Independent Directors (IDC)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=EA2C1E0B-CECB-4133-94B6-D7927EF833C7-175733.zip) |
| 2026-07-27 | [Letter of Offer](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7026FDF3-70F3-433C-A016-0E0A99006600-081129.pdf) |
| 2026-07-25 | [Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=89156853-a3d4-445c-931b-61d3d3cffb8e.pdf) |
| 2026-07-25 | [Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7562922e-bccf-49fe-a33f-d23492cfaf94.pdf) |
| 2026-07-16 | [Updates on Open Offer (Identified Date)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=DB02C68A-A0D2-485C-B463-AC9BCF38ED2E-124504.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-14 | [Results: Unaudited Financial Results For The Quarter Ended June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6c8fd705-31a7-4944-bf30-a5774427c91c.pdf) |
| 2026-05-16 | [Results: Audited Standalone Financial Results For The Quarter & Year Ended March 31 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ba9f9bce-c5e5-4aa8-87e8-3295cc60e3f6.pdf) |
| 2026-02-06 | [Standalone Unaudited Financial Results For The Quarter Ended December 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b21ccf5a-7831-4a51-a58b-3a7e1e17aa28.pdf) |
| 2025-11-11 | [Results: Unaudited Financial Results For The Quarter And Half Year Ended Ended September 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ed642152-35f0-489e-aeb5-a88ece286ad8.pdf) |
| 2025-07-26 | [Results: Standalone Unaudited Financial Results For The Quarter Ended June 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=71b4ba02-43ae-4074-bbdf-5edd8c7e1d24.pdf) |
| 2025-04-12 | [Audited Results For The Financial Year Ended 31.03.2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=149ea43d-ed47-4ed0-990d-4532d837ac88.pdf) |
| 2024-11-12 | [Results For The Quarter And Half Year Ended September 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8bee624d-1417-45a0-8daf-ba22aba843f9.pdf) |
| 2024-08-14 | [Unaudited Results For The 1St Quarter Ended 30.06.2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0e8b44c0-9c29-4741-b1a0-b1f27519ffea.pdf) |
| 2024-05-29 | [Audited Results For The Financial Year Ended 31.03.2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=157a8682-aa38-4204-87cd-2adcde2df1a2.pdf) |
| 2024-02-14 | [Unaudited Financial Results For The Quarter Ended 31.12.2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=61b17bde-55e4-4cac-b610-a5f8a79ec981.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Nov 2025 | [Concall - Nov 2025](https://nsearchives.nseindia.com/corporate/ENSER06_24112025145438_Investorpptsigned.pdf) |
| May 2024 | [Concall - May 2024](https://nsearchives.nseindia.com/corporate/ENSER_27052024183130_investorpptfinal.pdf) |
| Jun 2025 | [Concall - Jun 2025](https://nsearchives.nseindia.com/corporate/ENSER06_23062025063427_Investor_ppt_finalsigned.pdf) |
| Dec 2024 | [Concall - Dec 2024](https://nsearchives.nseindia.com/corporate/ENSER06_27122024141851_Enser_Presentation_signed.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Financial Year 2025 from nse](https://archives.nseindia.com/annual_reports/SME_AR_28193_ENSER_2024_2025_A_46473322_02092025185732.pdf) |
| from nse | [Financial Year 2024 from nse](https://archives.nseindia.com/annual_reports/SME_AR_25633_ENSER_2023_2024_03092024221116.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/bfb193d6-3d5a-4b18-bb8d-4643a8c9772f.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/807c992c-3f82-48a3-a67e-e54b8d8af497.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a723291b-b773-4455-aaf0-d3e58d1faee5.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/526504/76306526504.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/526504/72817526504.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/526504/67932526504.pdf) |
| from bse | [Annual Report 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/526504/5265040319.pdf) |
| from bse | [Annual Report 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport/526504/5265040318.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:58:51.365Z.